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Description of Case
A 28-year-old man presented to a
referral hospital in Harare, Zimbabwe,
with a 6 month history of intermittent
fevers and headaches. He worked as a
game ranger in the Zambezi Valley. At
the onset of his illness, he was treated for
malaria with intravenous quinine at a
district hospital despite a negative rapid
diagnostic test. The symptoms worsened
in the 2 months preceding presentation
with onset of drenching night sweats and
significant weight loss. He had been
extensively investigated over this period
at a private hospital in Harare, where
investigations for HIV infection, diabe-
tes mellitus, and cryptococcal and tuber-
culous meningitis were negative. A
lymph node biopsy had shown reactive
changes only. Nevertheless, he was
commenced on treatment for tuberculo-
sis. However, he continued to deterio-
rate, developing progressive generalised
rigidity and episodes of confusion. On
examination he was very ill, delirious,
and febrile with a temperature of 39uC
but had no cutaneous lesions and no
lymphadenopathy. He had generalised
i n c r e a s e dt o n ea n dt h ek e r n i gs i g nw a s
negative. He had brisk reflexes generally
and the plantar reflexes were upgoing.
However, there were no focal neurolog-
ical signs and examination of the other
systems was unremarkable.
Human African trypanosomiasis was
suspected and confirmed on a thin blood
smear (Figure 1). The cerebrospinal fluid
(CSF) showed a protein of 4.6 g/L (0.15–
0.45 g/L), glucose 4.3 mmol/L (2.8–
4.2 mmol/L) and 6 mononuclear cells/
mm
3. No specific search for trypanosomes
was performed on the CSF, which was
analysed before the diagnosis was made.
The blood glucose was 6.1 mmol/L and
the full blood count was as follows: white
cell count 6.28610
3/mL, haemoglobin
7.5 g/dL, and platelets 145610
3/mL.
The urea and electrolytes were normal.
The final diagnosis was stage 2 rhode-
siense trypanosomiasis. The specific drugs
for this stage (suramin and melarsoprol)
were available from the World Health
Organization (WHO) emergency country
stock. Despite melarsoprol being availed
urgently, the patient died, before the initial
dose was administered.
Consent: Informed written consent for
publication of the case was obtained from
the patient’s relatives.
Case Discussion
There is considerable underdiagnosis of
human trypanosomiasis caused by Try-
panosoma brucei rhodesiense in sub-Saharan
Africa [1]. This is not easily amenable to
quantification in low endemic countries
such as Zimbabwe. The majority of the
few cases originating from Zimbabwe are
diagnosed outside the country, mainly in
Britain and South Africa [2,3]. It is likely
that the few cases presenting to local
health facilities are getting missed, even
though treatment is readily available
through WHO initiatives [4]. This is also
important for other sub-Saharan African
countries with a low disease burden. There
are also frequent reports of the disease in
visitors to sub-Saharan Africa in general,
in whom the diagnosis may also be missed
or unduly delayed [5–7].
In an epidemic in Uganda, it was
estimated that more than a third of cases
of rhodesiense trypanosomiasis went un-
detected and unreported [1]. There were
approximately 12 undiagnosed deaths for
every reported case. The median time
between presentation and diagnosis was
30 days, which implies that lack of access
to health care facilities and the health-
seeking behaviour of the affected popula-
tions were not the only contributing
factors. Poor diagnostic facilities, shortage
of experienced laboratory personnel, and
reduced awareness of the disease among
health care workers are probably signifi-
cant determinants of both underdiagnosis
and delayed diagnosis of the disease.
In general, there is a reduced knowledge
of neglected tropical diseases among
medical practitioners in sub-Saharan
Africa [8]. This may be marked in areas
where particular conditions are perceived
to be uncommon and leads to failure to
optimally deploy the available limited
diagnostic modalities for maximal benefit.
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Learning Points
N History of relevant exposure is the cornerstone of the diagnosis of most tropical
infections.
N Microscopy is a vital skill that should be preserved as new diagnostic methods
for malaria and tuberculosis emerge.
N Political and social instability provides the right milieu for the reemergence of
previously controlled diseases.
N Clinicians in areas where HIV, tuberculosis, and malaria are common must
remain open-minded regarding other, less common but severe and potentially
fatal treatable conditions.
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(LK) received further training in tropical
infections, which may have enhanced the
final diagnostic process. This potential
knowledge gap must be addressed during
both initial medical training and through
continuing medical education, particularly
for health workers in regions at risk for
specific conditions.
Specifically, the severe HIV and tuber-
culosis epidemic in sub-Saharan Africa has
also helped push rhodesiense trypanosomi-
asis from the diagnostic limelight. Numer-
ous neurological conditions with a similar
clinical picture occur inHIVinfection, and,
rightly so, these are the main focus of
clinical decision making. Unfortunately,
this is frequently accompanied by a failure
to consider alternative causes, especially
when the HIV tests are negative. This
diagnostic blind spot is also seen when
malaria is the initial clinical diagnosis, as
illustrated in this case. Clinicians in sub-
Saharan Africa frequently over-treat ma-
laria, i.e., treating even when sensitive
diagnostic tests are negative [9]. The
increasing use of these rapid diagnostic
tests for malaria is also making routine
blood microscopy redundant, inadvertently
eliminating the opportunity of making
other, incidental diagnoses. The increasing
reliance on automated haematological
analysis can potentially worsen the prob-
lem, and this oversight can occur even in
countries with advanced health systems.
Trypanosomiasis in Zimbabwe
The first case of human trypanosomiasis
originating from Zimbabwe, then named
Southern Rhodesia, was diagnosed in
London in 1911 [10]. The disease has
always been uncommon in the country,
with only a few sporadic cases reported in
the local population annually in the 1960s
and 1970s, albeit more regularly than at
present [11,12]. T. brucei rhodesiense, which
causes an acute, relatively rapidly progres-
sive disease, is the implicated protozoan in
Zimbabwe and the rest of southern and
eastern Africa. In 1968, it was noted that
the epidemiology of the disease in the
country had not changed since the initial
cases were reported [13]. The disease has
always been localised in the Zambezi
Valley; between Kariba and the Chewore
River, Kanyemba, the Hunyani River
area between the Zambezi Escarpment
and Mashumbi Pools, and the area north
of Mashumbi Pools [12].
The past decade has seen severe
political, social, and economic problems
in the country, culminating in what is now
internationally recognised as the worst
hyperinflation in the world in recent times
[14,15]. This resulted in gross under-
funding of social and health services,
disrupting disease surveillance and control
programmes. There has also been an
accelerated skills flight adversely affecting
all sectors of the health and ancillary
systems. Not surprisingly, there has been a
re-emergence of previously well-controlled
diseases such as measles and cholera
[16,17]. It is crucial to ensure that this
case is not just the tip of the iceberg, as
there is no active surveillance for trypano-
somiasis in the country.
The Presenting Case
The role of history in clinical medicine
cannot be overemphasized. In this case,
the patient lived in the right geographical
region and his occupation placed him at
heightened risk of contracting trypanoso-
miasis. Consideration of this should have
triggered appropriate investigations much
earlier in the disease course. Generally
with tropical infections, exposure to par-
ticular geographical areas is crucial in
guiding initial investigations and treat-
ment. This maxim is equally relevant in
both developing and developed countries
and can be lifesaving. Finally, this case
demonstrates the continued relevance of
microscopy as newer, faster diagnostic
methods for various diseases are being
developed and introduced. This vital skill
should not be left to wane, particularly in
frontline hospitals in resource-limited set-
tings.
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Figure 1. Peripheral blood smear showing Trypanosome brucei rhodesiense. (Giemsa6100, oil immersion.)
doi:10.1371/journal.pntd.0000823.g001
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